logo
Book a meeting
AMNIOCHOR

Amniochor

Biotechnology, Chicago, Illinois, 60014, United States, 1-10 Employees

amniochor.com

  • facebook
  • twitter
  • LinkedIn

Who is AMNIOCHOR

AmnioChor was founded by the integration of science, medicine, and engineering and is a biotech company based in plurinatal stem cell technology. The Company has identified a source and m...

Read More

lock icon Get Full Access
map
  • Chicago, Illinois, 60014, United States Headquarters: Chicago, Illinois, 60014, United States
  • 2008 Date Founded: 2008
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8099

checked-icon Does something look wrong? Fix it. | View contact records from AMNIOCHOR

AMNIOCHOR Org Chart and Mapping

Employees
Dale Woodbury

Dale Woodbury

Chief Scientific Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for AMNIOCHOR
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding AMNIOCHOR

Answer: AMNIOCHOR's headquarters are located at Chicago, Illinois, 60014, United States

Answer: AMNIOCHOR's official website is https://amniochor.com

Answer: AMNIOCHOR's revenue is Under $1 Million

Answer: AMNIOCHOR's SIC: 8099

Answer: AMNIOCHOR has 1-10 employees

Answer: AMNIOCHOR is in Biotechnology

Answer: AMNIOCHOR contact info: Phone number: Website: https://amniochor.com

Answer: AmnioChor was founded by the integration of science, medicine, and engineering and is a biotech company based in plurinatal stem cell technology. The Company has identified a source and method of acquiring and preserving human stem cells. AmnioChors stem cells, Mesenchymal in composition, will allow a tremendous expansion of the private stem cell storage industry and stem cell based therapies. The Mesenchymal stem cells that reside in the amnion, are readily available in pristine quality at childbirth. AmnioChor has developed the technology to capture and cryopreserve the placental tissue, and is building a new tissue bank. The OMNIBANK will comprise a fee based personal storage, and a separate community component based on tissue donations. AmnioChors long term vision is based on the significant cached value of their cells and what they will provide to the burgeoning regenerative medicine and cellular therapy industries, the future of healthcare.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access